| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |